{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:00:06Z","timestamp":1781092806531,"version":"3.54.1"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Gestational diabetes mellitus (GDM), defined as glucose intolerance occurring or first detected during pregnancy, affects approximately 8% of pregnancies worldwide. The dysfunction of trophoblasts in pregnancies complicated by GDM is associated with changes in trophoblast cell functions, resulting in compromised proliferation and regulation of the cell cycle. Cyclin B1 (CCNB1), a pivotal controller of the start of mitosis, is crucial in these mechanisms. Nevertheless, the precise function of CCNB1 in trophoblast dysfunction related to GDM has not been extensively investigated. The aim of this study was to investigate CCNB1\u2019s role in high glucose (HG)-triggered trophoblast. Herein, we revealed that in HG-stimulated HTR8\/SVneo cells, CCNB1 is highly expressed. Knockdown of CCNB1 significantly promotes the growth of HG-stimulated HTR8\/SVneo cells and suppresses inflammation (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.05). Additionally, reducing CCNB1 expression significantly improves glucose uptake and inhibits the Wnt\/\u03b2-catenin pathway in HG-stimulated HTR8\/SVneo cells (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.05). In conclusion, our study demonstrated that the deletion of CCNB1 can alleviate trophoblast dysfunction induced by HG in GDM through the Wnt\/\u03b2-catenin pathway. This suggests that CCNB1 may be a potential target for managing GDM. Although our results underscore the potential therapeutic benefits of reducing CCNB1 in mitigating trophoblast dysfunction, it is important to note that the study is limited by its reliance on a single cell line and the absence of\n                    <jats:italic>in vivo<\/jats:italic>\n                    validation.\n                  <\/jats:p>","DOI":"10.1515\/med-2024-1119","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T10:51:03Z","timestamp":1736765463000},"source":"Crossref","is-referenced-by-count":2,"title":["Knockdown of CCNB1 alleviates high glucose-triggered trophoblast dysfunction during gestational diabetes via Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1515","volume":"20","author":[{"given":"Biru","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Obstetrical, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou , Zhejiang, 325000 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrical, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou , Zhejiang, 325000 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nini","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Obstetrical, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou , Zhejiang, 325000 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrical, The First Affiliated Hospital of Wenzhou Medical University , Nanbaixiang Street, Ouhai District , Wenzhou , Zhejiang, 325000 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"2025122201305459509_j_med-2024-1119_ref_001","doi-asserted-by":"crossref","unstructured":"Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: Systematic review and meta-analysis. BMJ. 2022;377:e067946. 10.1136\/bmj-2021-067946.","DOI":"10.1136\/bmj-2021-067946"},{"key":"2025122201305459509_j_med-2024-1119_ref_002","doi-asserted-by":"crossref","unstructured":"Sweeting A, Wong J, Murphy HR, Ross GP. A clinical update on gestational diabetes mellitus. Endocr Rev. 2022;43(5):763\u201393. 10.1210\/endrev\/bnac003.","DOI":"10.1210\/endrev\/bnac003"},{"key":"2025122201305459509_j_med-2024-1119_ref_003","doi-asserted-by":"crossref","unstructured":"Price SAL, Moses RG. Gestational diabetes mellitus and glucose sample handling. Diabetes Care. 2020;43(7):1371\u20132. 10.2337\/dci20-0021.","DOI":"10.2337\/dci20-0021"},{"key":"2025122201305459509_j_med-2024-1119_ref_004","doi-asserted-by":"crossref","unstructured":"Lindsay RS, Mackin ST, Nelson SM. Gestational diabetes mellitus-right person, right treatment, right time? BMC Med. 2017;15(1):163. 10.1186\/s12916-017-0925-2.","DOI":"10.1186\/s12916-017-0925-2"},{"key":"2025122201305459509_j_med-2024-1119_ref_005","doi-asserted-by":"crossref","unstructured":"Francis EC, Kechris K, Jansson T, Dabelea D, Perng W. Novel metabolic subtypes in pregnant women and risk of early childhood obesity in offspring. JAMA Netw Open. 2023;6(4):e237030. 10.1001\/jamanetworkopen.2023.7030.","DOI":"10.1001\/jamanetworkopen.2023.7030"},{"key":"2025122201305459509_j_med-2024-1119_ref_006","doi-asserted-by":"crossref","unstructured":"McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. 10.1038\/s41572-019-0098-8.","DOI":"10.1038\/s41572-019-0098-8"},{"key":"2025122201305459509_j_med-2024-1119_ref_007","doi-asserted-by":"crossref","unstructured":"Cui SS, Zhang P, Sun L, Yuan YL, Wang J, Zhang FX, et al. Mucin1 induced trophoblast dysfunction in gestational diabetes mellitus via Wnt\/beta-catenin pathway. Biol Res. 2023;56(1):48. 10.1186\/s40659-023-00460-3.","DOI":"10.1186\/s40659-023-00460-3"},{"key":"2025122201305459509_j_med-2024-1119_ref_008","doi-asserted-by":"crossref","unstructured":"Schnittger A, De Veylder L. The dual face of cyclin B1. Trends Plant Sci. 2018;23(6):475\u20138. 10.1016\/j.tplants.2018.03.015.","DOI":"10.1016\/j.tplants.2018.03.015"},{"key":"2025122201305459509_j_med-2024-1119_ref_009","doi-asserted-by":"crossref","unstructured":"Xia P, Zhang H, Xu K, Jiang X, Gao M, Wang G, et al. MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Cell Death Dis. 2021;12(7):691. 10.1038\/s41419-021-03973-5.","DOI":"10.1038\/s41419-021-03973-5"},{"key":"2025122201305459509_j_med-2024-1119_ref_010","doi-asserted-by":"crossref","unstructured":"Feng H, Liu J, Qiu Y, Liu Y, Saiyin H, Liang X, et al. RNA-binding motif protein 43 (RBM43) suppresses hepatocellular carcinoma progression through modulation of cyclin B1 expression. Oncogene. 2020;39(33):5495\u2013506. 10.1038\/s41388-020-1380-7.","DOI":"10.1038\/s41388-020-1380-7"},{"key":"2025122201305459509_j_med-2024-1119_ref_011","doi-asserted-by":"crossref","unstructured":"Jing MY, Xie LD, Chen X, Zhou Y, Jin MM, He WH, et al. Circ-CCNB1 modulates trophoblast proliferation and invasion in spontaneous abortion by regulating miR-223\/SIAH1 axis. Endocrinology. 2022;163(8). 10.1210\/endocr\/bqac093.","DOI":"10.1210\/endocr\/bqac093"},{"key":"2025122201305459509_j_med-2024-1119_ref_012","doi-asserted-by":"crossref","unstructured":"Su H, Wan Q, Tian XJ, He FF, Gao P, Tang H, et al. MAD2B contributes to podocyte injury of diabetic nephropathy via inducing cyclin B1 and Skp2 accumulation. Am J Physiol Ren Physiol. 2015;308(7):F728\u201336. 10.1152\/ajprenal.00409.2014.","DOI":"10.1152\/ajprenal.00409.2014"},{"key":"2025122201305459509_j_med-2024-1119_ref_013","doi-asserted-by":"crossref","unstructured":"Xie B, Wang S, Jiang N, Li JJ. Cyclin B1\/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Lett. 2019;443:56\u201366. 10.1016\/j.canlet.2018.11.019.","DOI":"10.1016\/j.canlet.2018.11.019"},{"key":"2025122201305459509_j_med-2024-1119_ref_014","doi-asserted-by":"crossref","unstructured":"Patel JR, Banjara B, Ohemeng A, Davidson AM, Boue SM, Burow ME, et al. Novel therapeutic combination targets the growth of letrozole-resistant breast cancer through decreased cyclin B1. Nutrients. 2023;15(7). 10.3390\/nu15071632.","DOI":"10.3390\/nu15071632"},{"key":"2025122201305459509_j_med-2024-1119_ref_015","doi-asserted-by":"crossref","unstructured":"Hao Y, Zhu Y, Sun F, Xu D, Wang C. MicroRNA-30c-5p arrests bladder cancer G2\/M phase and suppresses its progression by targeting PRC1-mediated blocking of CDK1\/Cyclin B1 axis. Cell Signal. 2023;110:110836. 10.1016\/j.cellsig.2023.110836.","DOI":"10.1016\/j.cellsig.2023.110836"},{"key":"2025122201305459509_j_med-2024-1119_ref_016","doi-asserted-by":"crossref","unstructured":"Abouleisa RRE, Salama ABM, Ou Q, Tang XL, Solanki M, Guo Y, et al. Transient cell cycle induction in cardiomyocytes to treat subacute ischemic heart failure. Circulation. 2022;145(17):1339\u201355. 10.1161\/CIRCULATIONAHA.121.057641.","DOI":"10.1161\/CIRCULATIONAHA.121.057641"},{"key":"2025122201305459509_j_med-2024-1119_ref_017","doi-asserted-by":"crossref","unstructured":"Cho KW, Andrade M, Bae S, Kim S, Eyun Kim J, Jang EY, et al. Polycomb group protein CBX7 represses cardiomyocyte proliferation through modulation of the TARDBP\/RBM38 axis. Circulation. 2023;147(24):1823\u201342. 10.1161\/CIRCULATIONAHA.122.061131.","DOI":"10.1161\/CIRCULATIONAHA.122.061131"},{"key":"2025122201305459509_j_med-2024-1119_ref_018","doi-asserted-by":"crossref","unstructured":"Baz B, Riveline JP, Gautier JF. Endocrinology of pregnancy: Gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol. 2016;174(2):R43\u201351. 10.1530\/EJE-15-0378.","DOI":"10.1530\/EJE-15-0378"},{"key":"2025122201305459509_j_med-2024-1119_ref_019","doi-asserted-by":"crossref","unstructured":"Ray GW, Zeng Q, Kusi P, Zhang H, Shao T, Yang T, et al. Genetic and inflammatory factors underlying gestational diabetes mellitus: A review. Front Endocrinol (Lausanne). 2024;15:1399694. 10.3389\/fendo.2024.1399694.","DOI":"10.3389\/fendo.2024.1399694"},{"key":"2025122201305459509_j_med-2024-1119_ref_020","doi-asserted-by":"crossref","unstructured":"Basil B, Mba IN, Myke-Mbata BK, Adebisi SA, Oghagbon EK. A first trimester prediction model and nomogram for gestational diabetes mellitus based on maternal clinical risk factors in a resource-poor setting. BMC Pregnancy Childbirth. 2024;24(1):346. 10.1186\/s12884-024-06519-7.","DOI":"10.1186\/s12884-024-06519-7"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2024-1119\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2024-1119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T01:43:03Z","timestamp":1766367783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2024-1119\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6,9]]},"published-print":{"date-parts":[[2025,6,9]]}},"alternative-id":["10.1515\/med-2024-1119"],"URL":"https:\/\/doi.org\/10.1515\/med-2024-1119","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20241119"}}